• Contact Us

    • Resource Center

    May 22, 2019
      |  Policy

    Policy on Disclosure and Management of Financial Conflicts of Interest related to Public Health Service Research

    Howell BA
    Keywords: NIH, Policies, RENAsymSoftware: RENAsym™Division: DILIsym Services

    Policy for disclosure & management of financial conflicts of interest related to PHS Research, with an issue date of the Notice of Award on or after August 24, 2012.

     

    Click Here to View

    Contact Us About This Policy

    Similar Resources

    Simulations Plus Press Release
    02/23/2021
    Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration
    Keywords: DILIsym, molecular, NIH, Small Business Innovation Research (SBIR)Software: DILIsym®Division: Simulations Plus
    Read More
    Simulations Plus Blog
    12/03/2020
    A message from Brett Howell, President of DILIsym Services
    Howell BA
    Keywords: DILI-sim, drug efficacy, drug safety, IPFsym, mechanistic modeling, QSP (quantitative systems pharmacology) modeling software, remdesivir, RENAsymDivision: DILIsym Services
    Read More
    Simulations Plus Poster
    11/12/2020
    Development of Quantitative Systems Toxicology Model to Predict Drug Induced Acute Kidney Injury via mtDNA Depletion Pathway
    Tallapaka SB, Hamzavi N, Gebremichael Y, Siler SQ, Woodhead JL
    Keywords: Acute kidney injury (AKI), Hepatitis B, HIV, mitochondrial DNA (mtDNA), RENAsymSoftware: GastroPlus®, RENAsym™Conference: ACoPDivision: DILIsym Services
    Read More Click Here to View